HealthEquity (NASDAQ:HQY) Issues FY 2027 Earnings Guidance

Key Points

• HealthEquity issued FY 2027 guidance of $4.660–$4.730 in earnings per share, above the $4.560 analyst consensus, while revenue guidance was approximately $1.4 billion, in line with estimates.
• The company’s latest quarter exceeded expectations, with EPS of $1.24 versus the $1.19 consensus and revenue of $350.73 million compared with estimates of $349.22 million.
• Analyst sentiment remains favorable, with 11 Buy ratings and an average target price of $110.93; institutional investors own 99.55% of HealthEquity shares.

HealthEquity (NASDAQ:HQY - Get Free Report) updated its FY 2027 earnings guidance on Thursday morning. The company provided earnings per share guidance of 4.660-4.730 for the period, compared to the consensus estimate of 4.560. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

HealthEquity Price Performance

HealthEquity stock opened at $104.42 on Thursday. The stock has a market cap of $8.73 billion, a price-to-earnings ratio of 39.11, a PEG ratio of 1.77 and a beta of 0.21. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The business has a 50-day simple moving average of $97.77 and a 200 day simple moving average of $87.71. HealthEquity has a 52 week low of $72.76 and a 52 week high of $107.62.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, research analysts forecast that HealthEquity will post 3.92 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on HQY shares. Weiss Ratings raised HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a research note on Friday, June 5th. BTIG Research increased their price objective on HealthEquity from $110.00 to $115.00 and gave the company a "buy" rating in a research report on Friday, July 24th. Wells Fargo & Company set a $111.00 price objective on HealthEquity in a report on Monday, June 1st. Citizens Jmp boosted their target price on HealthEquity from $110.00 to $111.00 and gave the stock a "market outperform" rating in a research report on Monday, June 1st. Finally, Royal Bank Of Canada lifted their price target on shares of HealthEquity from $100.00 to $108.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 3rd. Eleven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, HealthEquity has an average rating of "Moderate Buy" and an average target price of $110.93.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares of the company's stock, valued at $4,963,180. This represents a 4.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 7,966 shares of company stock worth $756,770. Corporate insiders own 1.60% of the company's stock.

Institutional Trading of HealthEquity

Several large investors have recently modified their holdings of the business. Fiduciary Trust Co increased its position in shares of HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company's stock worth $348,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC lifted its holdings in HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company's stock valued at $60,000 after purchasing an additional 123 shares in the last quarter. Merit Financial Group LLC lifted its holdings in HealthEquity by 8.9% in the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company's stock valued at $200,000 after purchasing an additional 172 shares in the last quarter. Parallel Advisors LLC boosted its stake in HealthEquity by 14.3% during the 4th quarter. Parallel Advisors LLC now owns 1,387 shares of the company's stock worth $127,000 after purchasing an additional 173 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its stake in HealthEquity by 51.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 793 shares of the company's stock worth $73,000 after purchasing an additional 271 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source